| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Co-ceo And General Counsel | President And General Counsel | President &General Counsel
2 companies
Tomkiel Melissa M. serves as a Co-ceo And General Counsel at SRTAW and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 24 sells. Those positions are worth an estimated $9.5M at current prices.
Historically, Tomkiel Melissa M.'s trades have earned a middling insider score of 56/100 across 23 rated trades. Over a 12-month horizon, 39.1% of those trades were profitable, with an average 12-month return of -12.3%.
The biggest single holding is SRTA (~$9.5M) as Co-ceo And General Counsel. The recent filings there lean toward selling, a net 615,301 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 10, 2023 | SRTA Strata Critical Medical, Inc. | President And General Counsel | Sell | 39,951 | $2.90 | $115,722.71 | -0.9% | +36.8% | +32.6% | |
| Jan 9, 2023 | SRTA Strata Critical Medical, Inc. | President And General Counsel | Sell | 5,139 | $3.47 | $17,852.89 | -0.4% | -18.3% | -12.9% | |
| Oct 6, 2022 | SRTA Strata Critical Medical, Inc. | President And General Counsel | Sell | 4,366 | $3.97 | $17,335.20 | -1.0% | -12.7% | -39.4% |